Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with ehrlich ascites carcinoma

Ganesh Chandra Jagetia, Venkatasubbaiah Ashoka Kumar Venkatesha

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The effect of radiation on tumor tissue can be optimized by adding radiosensitizing agents, in order to achieve a greater degree of tumor damage than expected from the use of either treatment alone. The ethanolic extract of Aphanamixis polystachya (APE) was tested in Swiss albino mice transplanted with Ehrlich ascites carcinoma (EAC) and exposed to various doses of γ-radiation. EAC mice received 0, 10, 25, 50, 75, 100, 150 or 200 mg/kg body wt APE before exposure to 6 Gy γ-radiation followed by once daily administration for another 8 consecutive days post-irradiation. The optimum radiosensitizing dose was found to be 50 mg/kg APE that was further tested in EAC mice exposed to 0, 1, 2, 4, 6 or 8 Gy hemi body γ-radiation. The best effect of APE and radiation was observed for 6 Gy γ-radiation. The splitting of 50 mg into two equal fractions of 25 mg and administering the split dose with a gap of 8 h on 1, 3, 5, 7 or 9 d of tumor inoculation resulted in an increased survival even when the drug was administered at late stages (day 5) of tumor development. The APE treatment before irradiation elevated lipid peroxidation followed by a reduction in the glutathione contents. Treatment of tumor bearing mice with APE before irradiation further reduced the activities of various antioxidant enzymes like glutathione peroxidase, glutathione-s- transferase, superoxide dismutase and catalase at different post last drug administration (PLDA) times.

Original languageEnglish
Pages (from-to)69-77
Number of pages9
JournalBiological and Pharmaceutical Bulletin
Volume28
Issue number1
DOIs
Publication statusPublished - 01-01-2005
Externally publishedYes

Fingerprint

Radiation Effects
Ascites
Carcinoma
Radiation Dosage
Neoplasms
Radiation
Radiation-Sensitizing Agents
Glutathione Peroxidase
Glutathione Transferase
Pharmaceutical Preparations
Catalase
Lipid Peroxidation
Superoxide Dismutase
Glutathione
Antioxidants
Enzymes

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science

Cite this

Jagetia, Ganesh Chandra ; Venkatesha, Venkatasubbaiah Ashoka Kumar. / Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with ehrlich ascites carcinoma. In: Biological and Pharmaceutical Bulletin. 2005 ; Vol. 28, No. 1. pp. 69-77.
@article{faa4c0b0d06647daa22dee2c29c18371,
title = "Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with ehrlich ascites carcinoma",
abstract = "The effect of radiation on tumor tissue can be optimized by adding radiosensitizing agents, in order to achieve a greater degree of tumor damage than expected from the use of either treatment alone. The ethanolic extract of Aphanamixis polystachya (APE) was tested in Swiss albino mice transplanted with Ehrlich ascites carcinoma (EAC) and exposed to various doses of γ-radiation. EAC mice received 0, 10, 25, 50, 75, 100, 150 or 200 mg/kg body wt APE before exposure to 6 Gy γ-radiation followed by once daily administration for another 8 consecutive days post-irradiation. The optimum radiosensitizing dose was found to be 50 mg/kg APE that was further tested in EAC mice exposed to 0, 1, 2, 4, 6 or 8 Gy hemi body γ-radiation. The best effect of APE and radiation was observed for 6 Gy γ-radiation. The splitting of 50 mg into two equal fractions of 25 mg and administering the split dose with a gap of 8 h on 1, 3, 5, 7 or 9 d of tumor inoculation resulted in an increased survival even when the drug was administered at late stages (day 5) of tumor development. The APE treatment before irradiation elevated lipid peroxidation followed by a reduction in the glutathione contents. Treatment of tumor bearing mice with APE before irradiation further reduced the activities of various antioxidant enzymes like glutathione peroxidase, glutathione-s- transferase, superoxide dismutase and catalase at different post last drug administration (PLDA) times.",
author = "Jagetia, {Ganesh Chandra} and Venkatesha, {Venkatasubbaiah Ashoka Kumar}",
year = "2005",
month = "1",
day = "1",
doi = "10.1248/bpb.28.69",
language = "English",
volume = "28",
pages = "69--77",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "1",

}

Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with ehrlich ascites carcinoma. / Jagetia, Ganesh Chandra; Venkatesha, Venkatasubbaiah Ashoka Kumar.

In: Biological and Pharmaceutical Bulletin, Vol. 28, No. 1, 01.01.2005, p. 69-77.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Enhancement of radiation effect by Aphanamixis polystachya in mice transplanted with ehrlich ascites carcinoma

AU - Jagetia, Ganesh Chandra

AU - Venkatesha, Venkatasubbaiah Ashoka Kumar

PY - 2005/1/1

Y1 - 2005/1/1

N2 - The effect of radiation on tumor tissue can be optimized by adding radiosensitizing agents, in order to achieve a greater degree of tumor damage than expected from the use of either treatment alone. The ethanolic extract of Aphanamixis polystachya (APE) was tested in Swiss albino mice transplanted with Ehrlich ascites carcinoma (EAC) and exposed to various doses of γ-radiation. EAC mice received 0, 10, 25, 50, 75, 100, 150 or 200 mg/kg body wt APE before exposure to 6 Gy γ-radiation followed by once daily administration for another 8 consecutive days post-irradiation. The optimum radiosensitizing dose was found to be 50 mg/kg APE that was further tested in EAC mice exposed to 0, 1, 2, 4, 6 or 8 Gy hemi body γ-radiation. The best effect of APE and radiation was observed for 6 Gy γ-radiation. The splitting of 50 mg into two equal fractions of 25 mg and administering the split dose with a gap of 8 h on 1, 3, 5, 7 or 9 d of tumor inoculation resulted in an increased survival even when the drug was administered at late stages (day 5) of tumor development. The APE treatment before irradiation elevated lipid peroxidation followed by a reduction in the glutathione contents. Treatment of tumor bearing mice with APE before irradiation further reduced the activities of various antioxidant enzymes like glutathione peroxidase, glutathione-s- transferase, superoxide dismutase and catalase at different post last drug administration (PLDA) times.

AB - The effect of radiation on tumor tissue can be optimized by adding radiosensitizing agents, in order to achieve a greater degree of tumor damage than expected from the use of either treatment alone. The ethanolic extract of Aphanamixis polystachya (APE) was tested in Swiss albino mice transplanted with Ehrlich ascites carcinoma (EAC) and exposed to various doses of γ-radiation. EAC mice received 0, 10, 25, 50, 75, 100, 150 or 200 mg/kg body wt APE before exposure to 6 Gy γ-radiation followed by once daily administration for another 8 consecutive days post-irradiation. The optimum radiosensitizing dose was found to be 50 mg/kg APE that was further tested in EAC mice exposed to 0, 1, 2, 4, 6 or 8 Gy hemi body γ-radiation. The best effect of APE and radiation was observed for 6 Gy γ-radiation. The splitting of 50 mg into two equal fractions of 25 mg and administering the split dose with a gap of 8 h on 1, 3, 5, 7 or 9 d of tumor inoculation resulted in an increased survival even when the drug was administered at late stages (day 5) of tumor development. The APE treatment before irradiation elevated lipid peroxidation followed by a reduction in the glutathione contents. Treatment of tumor bearing mice with APE before irradiation further reduced the activities of various antioxidant enzymes like glutathione peroxidase, glutathione-s- transferase, superoxide dismutase and catalase at different post last drug administration (PLDA) times.

UR - http://www.scopus.com/inward/record.url?scp=18444385056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18444385056&partnerID=8YFLogxK

U2 - 10.1248/bpb.28.69

DO - 10.1248/bpb.28.69

M3 - Article

VL - 28

SP - 69

EP - 77

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 1

ER -